What is the recommended starting dose of trazodone for an adult with insomnia, and how should the dose be adjusted for elderly, frail, or patients with hepatic impairment?

Trazodone Starting Dose

Major clinical guidelines recommend AGAINST using trazodone for insomnia treatment, but if it is prescribed despite this recommendation, the FDA-approved starting dose is 150 mg/day in divided doses for depression, while off-label use for insomnia typically employs 25-50 mg at bedtime.

Critical Context: Guidelines Advise Against Trazodone for Insomnia

Before discussing dosing, it's essential to understand that both the 2017 American Academy of Sleep Medicine and the 2019 VA/DoD guidelines explicitly recommend against using trazodone for insomnia 1, 2. The evidence shows no significant differences in sleep efficiency or discontinuation rates compared to placebo, and the low-quality efficacy data is outweighed by its adverse effect profile 2.

FDA-Approved Dosing (For Depression)

The FDA label provides clear guidance for depression treatment 3:

• Initial dose: 150 mg/day in divided doses
• Start at low dose and increase gradually
• May increase by 50 mg/day every 3-4 days
• Outpatient maximum: 400 mg/day in divided doses
• Inpatient maximum: 600 mg/day in divided doses
• Administer shortly after a meal or light snack
• If drowsiness occurs, give major portion at bedtime or reduce dose

Off-Label Dosing for Insomnia (Despite Guidelines)

While not recommended by guidelines, clinical practice data shows 4, 5:

• Starting dose: 25-50 mg at bedtime
• Studies in insomnia used 50-150 mg before bedtime 2
• Low doses (50 mg) may suffice for hypnotic effect 5
• Can increase to 100 mg if 50 mg insufficient 4

Special Populations

Elderly/Frail Patients

• Start at 25 mg at bedtime 6
• One study showed 150 mg total daily (50 mg three times daily) was well-tolerated in elderly inpatients, but this was for depression, not insomnia 6
• Elderly patients are at greater risk for hyponatremia 3
• Use with caution due to increased fall risk and cognitive impairment

Hepatic Impairment

• Use with caution; no specific dosing guidelines available 3
• Trazodone has not been formally studied in hepatic impairment
• Consider starting at lower doses and titrating slowly

Renal Impairment

• Use with caution; no specific dosing guidelines available 3
• Not formally studied in renal impairment

Drug Interactions Requiring Dose Adjustment

Strong CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir) 3:

• Consider reducing trazodone dose based on tolerability

Strong CYP3A4 Inducers (e.g., carbamazepine, rifampin) 3:

• Consider increasing trazodone dose based on therapeutic response

Critical Safety Considerations

Common Pitfalls

• Daytime drowsiness and decreased appetite are significantly more common with trazodone 7
• Risk of priapism (rare but serious)
• Orthostatic hypotension, especially in elderly
• Serotonin syndrome risk when combined with other serotonergic agents

Discontinuation

• Gradually taper rather than stopping abruptly to avoid withdrawal symptoms 3

Screening Requirements

• Screen for bipolar disorder before initiating - trazodone can precipitate mania 3
• At least 14 days must elapse when switching to/from MAOIs 3

Clinical Reality vs. Guidelines

Despite guideline recommendations against trazodone for insomnia, it remains widely prescribed off-label. A 2023 clinical appraisal found that most practicing physicians disagreed with the statement that "trazodone should never be used as first-line medication for insomnia," though expert panels agreed with this statement based on limited evidence 8.

If prescribing trazodone for insomnia despite guidelines, start at 25-50 mg at bedtime, monitor closely for adverse effects (particularly daytime drowsiness, falls in elderly, and orthostatic hypotension), and consider alternative evidence-based treatments such as low-dose doxepin (3-6 mg), eszopiclone, or zolpidem 1.